Business programme

How Can We Address Cardiovascular Diseases for Aging Populations?
Panel session Reducing Risks to Human Health Submitted to the Coordinating Council for the Development of Continuing Medical Education for evaluation Non-communicable diseases are a heavy burden on the healthcare systems and economies of most of the world’s leading nations. Circulatory system diseases account for more than half of deaths, yet most of them can be prevented by impacting such adverse factors as tobacco use, unhealthy diet, obesity, lack of physical activity, and alcohol abuse. Such strategies are designed to reach the entire population. Public healthcare programmes, timely prevention, and access to innovative treatment methods should be the key to reducing mortality from coronary heart disease, heart failure, acute cardiovascular accidents, and cardiac rhythm disorders by almost a quarter. Particular attention should be paid to monitoring the main risk factors that have a direct impact on the development and progress of cardiovascular diseases such as high blood pressure, high cholesterol, and diabetes. What challenges do nations and international organizations face in using global experience to combat cardiovascular diseases? What best practices can and should be utilized? How will the implementation of a national project in Russia affect the life and health of the population in the future? What best regional experience in combating cardiovascular diseases is ready to be utilized at the national level?
Fighting Cancer: Strategies of the Future
Panel session Reducing Risks to Human Health As part of the series of events of the Content Foundation for the Development of Expert and Analytical Activities on improving the effectiveness of the national project ‘Combating Oncological Diseases’ Submitted to the Coordinating Council for the Development of Continuing Medical Education for evaluation According to WHO forecasts, an overall increase in life expectancy will lead to a 62% rise in malignant tumours and a 70% increase in the mortality rate from such tumours by 2040. Programmes to combat cancer are not only becoming a global trend, but a necessity. The national project Russia has been implementing since 2019 reflects the main mechanisms that are needed to improve the effectiveness of the healthcare system for cancer patients. Industry experts have proposed a number of measures to improve the project, such as introducing additional targets for the creation and implementation of the project as well as evaluating its effectiveness taking into account differences in the morbidity and mortality rates from various types of cancer, and incorporating oncohematology into the project. What specific steps are needed to improve the effectiveness of the cancer control system in Russia? What best international practices can not only help achieve, but also exceed the expected targets of the national project? The state guarantee programme already includes access to innovative diagnostics, however who is in charge of determining the need for biomarkers and the required amount? Does the industry have enough qualified personnel? What needs to be done to change the situation with access to modern treatment in the regions?
Has Genetics of the 21st Century Moved from Basic Research to Practical Medicine?
Panel session Reducing Risks to Human Health Today, the personalization of drug therapy and the identification of hereditary diseases and predispositions dictate the need to transition to genomic medicine and pharmacogenomics, which makes it possible to choose the most accurate treatment based on the human genotype. Taking into account the results of individual genetic testing, disease prevention and treatment programmes are a real resource for increasing life expectancy in numerous countries. National drug policies prioritize the creation of domestic innovative drugs by placing great hopes on biomedical cell products (BMPC), biotechnologies, and gene therapy. The first steps have already been taken: April will mark one year from the enactment of the Russian government’s resolution to approve the Federal Scientific and Technical Programme for the Development of Genetic Technologies in 2019–2027. How has the market for genetic services changed? How can we transition from scientific genetics to their use in practical medicine? What has been done to create the infrastructure of new scientific and educational genomic centres? How is the issue of training new highly qualified specialists being addressed? How can the introduction of molecular genetic diagnosis contribute to the development of personalized medicine? How is the development of gene therapeutic drugs and biomedical cell products progressing? How can we transition from understanding opportunities to action in precision medicine?
Fighting Infectious Diseases as a Step Towards Healthier Society
Panel session Reducing Risks to Human Health Submitted to the Coordinating Council for the Development of Continuing Medical Education for evaluation HIV, tuberculosis, and chronic viral hepatitis C are among the most pressing global health problems that pose a threat to people’s health and life. This makes it a top priority for the Russian healthcare system to assess the goal of preventing the spread of these diseases. According to the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, there are more than one million people with HIV in Russia, while more than 3.5 million individuals suffer from chronic hepatitis C, most of whom are within the age range of 35–50 years-old. The State HIV Prevention Strategy states that the therapy coverage rate for HIV patients should be increased to 90% by the end of 2020. This indicator is one of the targets in the 90-90-90 strategy of the Joint United Nations Programme on HIV and AIDS (UNAIDS). What solutions does the healthcare system propose to introduce effective measures to reduce the number of new HIV infections and deaths from AIDS and viral hepatitis C? What regional practices are most effective in combating major socially significant infections?
Artificial Intelligence in Medicine
Panel session Reducing Risks to Human Health Submitted to the Coordinating Council for the Development of Continuing Medical Education for evaluation The widespread integration and rapid development of modern digital technologies provides modern healthcare with a number of effective tools, including the main tool – artificial intelligence. Advances in AI have made it possible to enhance the accuracy of diagnosis and the effectiveness of targeted therapy not only through the AI analysis of a patient’s medical history, but also the individual’s genetic traits. In addition to clinical practice, AI is already being applied in biomedical research, and the development and introduction of new drugs and is also demonstrating a high level of efficiency in the analysis of medical images. Obviously, the use of AI is the future of healthcare, which makes issues of not only a medical nature, but also ethics and morality even more important. Will AI become a reliable aid for doctors? What challenges can AI help solve in healthcare? What are the ethical aspects of interaction between AI and patients? How should the cost of AI services in medicine be assessed? How should the use of AI in medicine be regulated at the legislative level? Will AI reduce or increase requirements for training doctors? What is being done today to make the high-tech medicine of the future accessible to all segments of the population?
Managing Lifelong Diabetes
Panel session Reducing Risks to Human Health In partnership with the Russian Society of Young Endocrinologists According to WHO forecasts, diabetes will become the seventh leading cause of death on the planet by 2030. Existing patterns of social behaviour, such as a sedentary lifestyle, bad habits, and an unhealthy diet are giving rise to the unhindered spread of type II diabetes. The situation is aggravated by the taboo surrounding diabetes since people try not to publicize their disease, which limits their accessibility to timely medical care. The problem requires an integrated approach, starting with disease prevention and drug production, and ending with support for people suffering from diabetes. Setting goals of this kind makes it necessary to meet the following challenges: raising awareness about the need for preventive measures; promoting achievements in diagnostic and therapeutic care; and introducing a model of social consciousness in which people should not be left alone to fight the disease. How can public awareness about risk reduction measures be increased? What successful case studies from health protection programmes can take early diabetes detection to a new level? How should people be motivated to change the paradigm of consciousness regarding an unhealthy lifestyle? What patient support programmes should be considered the most effective?
Managing Lifelong Diabetes. Youth program
Panel session Reducing Risks to Human Health In partnership with the Russian Society of Young Endocrinologists
Immunization as a Driver towards 80+
Panel session Reducing Risks to Human Health Submitted to the Coordinating Council for the Development of Continuing Medical Education for evaluation The World Health Organization cites immunization as one of the most effective healthcare measures. However, the increasing outbreaks of infections that can be prevented with vaccines over the past decade have called into question the stability of the success of universal vaccination. The problem of dwindling public trust in vaccines has become a priority for global healthcare. In 2019, the WHO included the rejection of vaccinations in its annual list of global threats to humanity for the first time. The experience of the last decade has shown that immunization measures don’t just need to catch up with the problem, but outpace it. Today, vaccination efforts must not only meet the goals of reducing morbidity and mortality rates, but also the goal of ensuring active longevity. Immunization throughout life is becoming a global trend. There is every reason to view the vaccination of older people as one of the most effective methods for achieving longevity targets. How can adult vaccination coverage be increased? What is the best practice for overcoming immunization barriers? How can we build a working system to inform people about the danger of rejecting vaccinations?